Adriana Feder: Clinical Trials

1 trial sponsored by Adriana Feder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Withdrawn 1
Phase 31Withdrawn 1

Follow Adriana Feder: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD
Ketamine, Midazolam - PTSD
Phase 2 / Phase 3WithdrawnAdriana Feder2014-12-012015-03-25

Conditions studied

Stress Disorders, Post-Traumatic (1)

Interventions

Ketamine (1)  ·  Midazolam (1)